Suchergebnisse - "de Sousa, Eric"

PubPharm (14)

1

The polarity and specificity of SARS-CoV2-specific T lymphocyte responses determine disease susceptibility

enthalten in: bioRxiv.org | 2024

von Fahrner, J. | Carrier, A. | De Sousa, E. | +52

2

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2024

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

3

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2023

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

4

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2023

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

5

METHOD OF PREPARING AND EXPANDING A POPULATION OF IMMUNE CELLS FOR CANCER THERAPY, POTENCY ASSAY FOR TUMOR RECOGNITION, BIOLOGICAL VACCINE PREPARATION AND EPITOPE TARGET FOR ANTIBODIES

enthalten in: Europäisches Patentamt | 2023

von MENDONÇA GORGULHO CAROLINA | RAMOS DE SOUSA ERIC SERAFIM | OLIVEIRA KAMIKI JÉSSICA | +3

6

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies

enthalten in: Oncoimmunology | 2023

von Bigenwald, C. | Haddad, Y. | Thelemaque, C. | +17

7

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2022

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

8

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2022

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

9

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

enthalten in: Cancer discovery | 2022

von Fahrner, J. | Lahmar, I. | Goubet, A. | +65

CommentIn: Cancer Discov. 2022 Apr 1;12(4):892-894. - PMID 35373282

10

Targeting Neoepitopes to Treat Solid Malignancies : Immunosurgery

enthalten in: Frontiers in immunology | 2021

von de Sousa, E. | Lérias, J. | Beltran, A. | +11